Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia.
Elisabetta ZapponeEmanuele CenciniMarzia DefinaAnna SicuranzaAlessandro GozzettiSara CiofiniDonatella RaspadoriBianca MecacciMonica BocchiaPublished in: Clinical case reports (2020)
A case of an early-relapsed high-risk T-ALL with high BCL-2 expression on leukemic blasts was successfully treated with decitabine and venetoclax, achieving a CR. We suggest decitabine and venetoclax should be synergistic in BCL2-positive ALL.